CAMPATH-IH in multiple sclerosis.

Eitemau Tebyg

• Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis.
  gan: Moreau, T, et al.
  Cyhoeddwyd: (1994)
• Inflammation, demyelination, and axonal degeneration: Three aspects of the pathogenesis of multiple sclerosis revealed by campath-1H treatment
  gan: Coles, A, et al.
  Cyhoeddwyd: (2003)
• Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients.
  gan: Calne, R, et al.
  Cyhoeddwyd: (1999)
• Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis.
  gan: Moreau, T, et al.
  Cyhoeddwyd: (1996)
• CAMPATH: from concept to clinic.
  gan: Waldmann, H, et al.
  Cyhoeddwyd: (2005)